Insider · CIK 0001237564
Steven M Paul
Files at RAPP (Rapport Therapeutics, Inc.). First filing Sep 15, 2025, latest Sep 15, 2025.
Steven M Paul files SEC Form 4 as director at RAPP (Rapport Therapeutics, Inc.). Since Sep 15, 2025, Steven M Paul has reported 1 open-market buy worth $1.0M and 0 open-market sells worth $0, the latest filed on Sep 15, 2025.
A track record needs three past buys with six months of prices behind them; Steven M Paul has 0, so none is measured yet.
The newest scored trade: bought $1.0M of RAPP on Sep 12, 2025, filed Sep 15, 2025, scored 67 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RAPP: Rapport Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 67Notable | Rapport Therapeutics, Inc. | $1.0M 41,666 shares | - | +232% from low-25% from high |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 12, 2025 | RAPP Rapport Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By Paul Capital Strategy III Fund LLC | +28,284 | $24.50 | $693k | 28,284 | Sep 15, 2025 |
| Sep 12, 2025 | RAPP Rapport Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By Paul Capital Strategy III Fund LLC | +13,382 | $24.97 | $334k | 41,666 | Sep 15, 2025 |
| Jun 17, 2025 | RAPP Rapport Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +21,850 | $0.00 | $0 | 21,850 | Jun 18, 2025 |
Questions about Steven M Paul
Answered from the filings on this page, as of the latest one.
Is Steven M Paul buying or selling?
Not in the last 12 months. Steven M Paul's latest open-market trade on SEC Form 4 was bought $1.0M of RAPP on Sep 12, 2025.
How did Steven M Paul's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Steven M Paul has 0.
Where does Steven M Paul file Form 4?
Steven M Paul has filed Form 4 at RAPP (Rapport Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.